Aptevo Therapeutics (APVO) stock Forecast for 2022 – 2026
Last update: 05-24-2022, 6:04
Sector: HealthcareThe share price of Aptevo Therapeutics Inc. (APVO) now
What analysts predict:: $28
52-week high/low: $31.76 / $3.45
50/200 Day Moving Average: $4.955 / $10.01
This figure corresponds to the average price over the previous 50/200 days. For Aptevo Therapeutics stocks, the 50-day moving average is the resistance level today.
For Aptevo Therapeutics stocks, the 200-day moving average is the resistance level today.
Are you interested in Aptevo Therapeutics Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Aptevo Therapeutics stock price in 2022, 2023, 2024, 2025, 2026. How much will one Aptevo Therapeutics share be worth in 2022 - 2026?
When should I take profit in Aptevo Therapeutics stock? When should I record a loss on Aptevo Therapeutics stock? What are analysts' forecasts for Aptevo Therapeutics stock? What is the future of Aptevo Therapeutics stock?
We forecast Aptevo Therapeutics stock performance using neural networks based on historical data on Aptevo Therapeutics stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
Aptevo Therapeutics stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2022, 2023, 2024, 2025 and 2026)
The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Aptevo Therapeutics shares. This happens once a day.
Historical and forecast chart of Aptevo Therapeutics stock
The chart below shows the historical price of Aptevo Therapeutics stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Aptevo Therapeutics stock price can be found in the table below.
Long-term forecasts by years.
Aptevo Therapeutics daily forecast for a month
| Date | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| May 26 | 5.18 | 4.91 | 5.36 | 9.11 |
| May 27 | 5.10 | 4.91 | 5.20 | 6.07 |
| May 28 | 4.86 | 4.65 | 5.03 | 8.20 |
| May 29 | 4.94 | 4.79 | 5.12 | 7.06 |
| May 30 | 5.05 | 4.81 | 5.30 | 10.19 |
| May 31 | 4.93 | 4.73 | 5.01 | 6.08 |
| Jun 01 | 4.81 | 4.56 | 5.09 | 11.54 |
| Jun 02 | 4.92 | 4.74 | 5.03 | 6.13 |
| Jun 03 | 5.15 | 4.99 | 5.34 | 6.98 |
| Jun 04 | 4.92 | 4.65 | 4.99 | 7.39 |
| Jun 05 | 4.76 | 4.52 | 4.92 | 8.71 |
| Jun 06 | 5.07 | 4.97 | 5.23 | 5.14 |
| Jun 07 | 5.09 | 4.81 | 5.25 | 9.22 |
| Jun 08 | 5.41 | 5.29 | 5.51 | 4.12 |
| Jun 09 | 5.75 | 5.52 | 5.95 | 7.72 |
| Jun 10 | 6.07 | 5.81 | 6.38 | 9.78 |
| Jun 11 | 6.17 | 5.83 | 6.34 | 8.84 |
| Jun 12 | 6.07 | 5.85 | 6.42 | 9.87 |
| Jun 13 | 5.66 | 5.40 | 5.82 | 7.77 |
| Jun 14 | 5.37 | 5.21 | 5.53 | 6.15 |
| Jun 15 | 5.40 | 5.28 | 5.59 | 5.74 |
| Jun 16 | 5.48 | 5.34 | 5.70 | 6.87 |
| Jun 17 | 5.64 | 5.51 | 5.74 | 4.12 |
| Jun 18 | 5.61 | 5.31 | 5.72 | 7.68 |
| Jun 19 | 5.41 | 5.12 | 5.55 | 8.45 |
| Jun 20 | 5.75 | 5.42 | 5.89 | 8.63 |
| Jun 21 | 5.61 | 5.50 | 5.69 | 3.53 |
| Jun 22 | 5.26 | 5.07 | 5.35 | 5.60 |
| Jun 23 | 5.01 | 4.77 | 5.16 | 8.02 |
| Jun 24 | 5.01 | 4.90 | 5.20 | 6.19 |
Aptevo Therapeutics Daily Price Targets
Aptevo Therapeutics Stock Forecast 05-26-2022.
Pessimistic target level: 4.91
Optimistic target level: 5.36
Aptevo Therapeutics Stock Forecast 05-27-2022.
Pessimistic target level: 4.91
Optimistic target level: 5.20
Aptevo Therapeutics Stock Forecast 05-28-2022.
Pessimistic target level: 4.65
Optimistic target level: 5.03
Aptevo Therapeutics Stock Forecast 05-29-2022.
Pessimistic target level: 4.79
Optimistic target level: 5.12
Aptevo Therapeutics Stock Forecast 05-30-2022.
Pessimistic target level: 4.81
Optimistic target level: 5.30
Aptevo Therapeutics Stock Forecast 05-31-2022.
Pessimistic target level: 4.73
Optimistic target level: 5.01
APVO (APVO) Monthly Stock Prediction for 2022
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jun. | 5.48 | 5.20 | 5.95 | 12.53 |
| Jul. | 5.55 | 4.93 | 5.97 | 17.37 |
| Aug. | 5.15 | 4.64 | 5.65 | 17.82 |
| Sep. | 4.76 | 4.40 | 5.36 | 17.82 |
| Oct. | 4.95 | 4.42 | 5.39 | 17.96 |
| Nov. | 5.58 | 5.26 | 6.06 | 13.16 |
| Dec. | 5.14 | 4.83 | 5.51 | 12.36 |
Aptevo Therapeutics forecast for this year
Aptevo Therapeutics Stock Prediction for Jun 2022
An uptrend is forecast for this month with an optimal target price of $5.48178. Pessimistic: $5.20. Optimistic: $5.95
Aptevo Therapeutics Stock Prediction for Jul 2022
An uptrend is forecast for this month with an optimal target price of $5.54702. Pessimistic: $4.93. Optimistic: $5.97
Aptevo Therapeutics Stock Prediction for Aug 2022
An downtrend is forecast for this month with an optimal target price of $5.15096. Pessimistic: $4.64. Optimistic: $5.65
Aptevo Therapeutics Stock Prediction for Sep 2022
An downtrend is forecast for this month with an optimal target price of $4.75691. Pessimistic: $4.40. Optimistic: $5.36
Aptevo Therapeutics Stock Prediction for Oct 2022
An uptrend is forecast for this month with an optimal target price of $4.95099. Pessimistic: $4.42. Optimistic: $5.39
Aptevo Therapeutics Stock Prediction for Nov 2022
An uptrend is forecast for this month with an optimal target price of $5.58225. Pessimistic: $5.26. Optimistic: $6.06
Aptevo Therapeutics Stock Prediction for Dec 2022
An downtrend is forecast for this month with an optimal target price of $5.13622. Pessimistic: $4.83. Optimistic: $5.51
Aptevo Therapeutics (APVO) Monthly Stock Prediction for 2023
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 4.71 | 4.52 | 4.88 | 7.39 |
| Feb | 4.57 | 4.27 | 4.91 | 12.99 |
| Mar | 4.56 | 4.22 | 4.99 | 15.52 |
| Apr | 3.94 | 3.43 | 4.39 | 21.94 |
| May | 3.78 | 3.45 | 4.19 | 17.78 |
| Jun | 3.90 | 3.56 | 4.20 | 15.29 |
| Jul | 4.40 | 4.20 | 4.87 | 13.80 |
| Aug | 4.68 | 4.39 | 5.06 | 13.36 |
| Sep | 5.21 | 4.74 | 5.52 | 14.10 |
| Oct | 5.28 | 4.70 | 5.85 | 19.66 |
| Nov | 5.67 | 5.16 | 6.05 | 14.67 |
| Dec | 5.40 | 4.85 | 5.66 | 14.28 |
Aptevo Therapeutics (APVO) Monthly Stock Prediction for 2024
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 5.46 | 4.96 | 5.96 | 16.66 |
| Feb | 4.80 | 4.32 | 5.08 | 14.92 |
| Mar | 4.56 | 4.13 | 4.74 | 12.76 |
| Apr | 4.46 | 3.93 | 4.99 | 21.27 |
| May | 4.41 | 4.24 | 4.96 | 14.50 |
| Jun | 4.30 | 3.76 | 4.58 | 17.88 |
| Jul | 4.80 | 4.23 | 5.34 | 20.79 |
| Aug | 5.15 | 4.56 | 5.48 | 16.93 |
| Sep | 4.57 | 4.15 | 4.80 | 13.45 |
| Oct | 4.49 | 4.27 | 4.73 | 9.83 |
| Nov | 4.49 | 4.23 | 4.97 | 14.89 |
| Dec | 4.19 | 3.93 | 4.55 | 13.63 |
Aptevo Therapeutics (APVO) Monthly Stock Prediction for 2025
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 4.35 | 3.87 | 4.80 | 19.28 |
| Feb | 5.09 | 4.52 | 5.29 | 14.54 |
| Mar | 5.33 | 5.14 | 5.78 | 11.12 |
| Apr | 4.91 | 4.50 | 5.22 | 13.75 |
| May | 5.14 | 4.72 | 5.36 | 11.90 |
| Jun | 4.99 | 4.49 | 5.42 | 17.21 |
| Jul | 5.36 | 4.92 | 6.02 | 18.18 |
| Aug | 5.95 | 5.38 | 6.30 | 14.60 |
| Sep | 5.08 | 4.40 | 5.32 | 17.20 |
| Oct | 4.23 | 4.04 | 4.56 | 11.51 |
| Nov | 4.36 | 4.13 | 4.52 | 8.69 |
| Dec | 4.17 | 3.86 | 4.46 | 13.37 |
Aptevo Therapeutics (APVO) Monthly Stock Prediction for 2026
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 4.88 | 4.56 | 5.50 | 17.04 |
| Feb | 4.98 | 4.43 | 5.31 | 16.45 |
| Mar | 4.91 | 4.54 | 5.33 | 14.86 |
| Apr | 4.86 | 4.23 | 5.23 | 19.11 |
| May | 4.51 | 3.95 | 4.81 | 17.86 |
| Jun | 4.80 | 4.18 | 5.01 | 16.44 |
| Jul | 4.69 | 4.44 | 5.24 | 15.22 |
| Aug | 4.74 | 4.33 | 5.16 | 16.09 |
| Sep | 4.24 | 3.91 | 4.45 | 12.13 |
| Oct | 4.31 | 4.08 | 4.78 | 14.72 |
| Nov | 3.67 | 3.38 | 4.06 | 16.76 |
| Dec | 3.55 | 3.15 | 3.99 | 21.14 |
Aptevo Therapeutics information and performance
Aptevo Therapeutics Inc is a clinical-stage biotechnology company. It focuses on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. The company develops its drug candidates using its ADAPTIR platform. The products under its pipeline are APVO436, which targets CD123 and CD3 and redirects T-cell cytotoxicity to the tumor; ALG.APV-527, for the treatment of a broad spectrum of cancers over-expressing the 5T4 tumor antigen, including mesothelioma, non-small-cell-lung, head & neck, pancreatic, renal, ovarian, and bladder cancers; and APVO603.
Aptevo Therapeutics Address
2401 4TH AVE., SUITE 1050, SEATTLE, WA, US
Market Capitalization: 23 033 300 $
Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.
EBITDA: -47 696 000 $
EBITDA is earnings before interest, income tax and depreciation of assets.
PE Ratio: None
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
PEG Ratio: N/A
Price/earnings to growth
DPS: N/A
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
DY: N/A
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS: -6.07
EPS shows how much of the net profit is accounted for by the common share.
Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: 0.544
Trailing PE: -
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward PE: -
Forward P/E uses projections of future earnings instead of final numbers.
EV To Revenue: 0.164
Enterprise Value (EV) /Revenue
EV To EBITDA: 0.348
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Shares Outstanding: 5007200
Number of issued ordinary shares
Shares Float: N/A
Number of freely tradable shares
Shares Short Prior Month: N/A
Shares Short Prior Month - the number of shares in short positions in the last month.
Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A
Aptevo Therapeutics (APVO) stock dividend
Aptevo Therapeutics last paid dividends on 01/01/1970. The next scheduled payment will be on 03/27/2020. The amount of dividends is $0 per share. If the date of the next dividend payment has not been updated, it means that the issuer has not yet announced the exact payment. As soon as information becomes available, we will immediately update the data. Bookmark our portal to stay updated.
Last Split Factor:
Last Split Date: 01/01/1970
Splitting of shares is an increase in the number of securities of the issuing company circulating on the market due to a decrease in their value at constant capitalization.
For example, a 5: 1 ratio means that the value of one share will decrease 5 times, the total amount will increase 5 times. It is important to understand that this procedure does not change the capitalization of the company, as well as the total value of assets held in private hands.